CD36, but not GPR120, is required for efficient fatty acid utilization during endurance exercise

Bioscience, Biotechnology and Biochemistry

Volumn 78, Issue 11, 2014, Pages 1871-1878

  Fujitani, Mina ^a   Matsumura, Shigenobu ^a   Masuda, Daisaku ^b   Yamashita, Shizuya ^b   Fushiki, Tohru ^a   Inoue, Kazuo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

13C labeled fatty acid oxidation measurement; CD36; Endurance exercise; GPR120; Indirect calorimetry

Indexed keywords

CALORIMETERS; CALORIMETRY; GENE EXPRESSION; METABOLISM; OXIDATION; PHYSIOLOGY;

CD36; CELLULAR TRANSPORT; ENDURANCE EXERCISE; ENERGY METABOLISM; FATTY ACID OXIDATION; G PROTEIN COUPLED RECEPTORS; GPR120; SIGNALING PATHWAYS;

FATTY ACIDS;

CD36 ANTIGEN; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GLUCOSE; O3FAR1 PROTEIN, MOUSE;

ANIMAL; CALORIMETRY; ENDURANCE; ENERGY METABOLISM; GENETICS; GENOTYPE; KNOCKOUT MOUSE; METABOLISM; MOUSE;

ANIMALS; ANTIGENS, CD36; CALORIMETRY; ENERGY METABOLISM; FATTY ACIDS; GENOTYPE; GLUCOSE; MICE; MICE, KNOCKOUT; PHYSICAL ENDURANCE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84938408634     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.940835     Document Type: Article

References (37)

1. Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, Wolfe RR. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am. J. Physiol. 1993;265:E380-E391.
2. Hickson RC, Rennie MJ, Conlee RK, Winder WW, Holloszy JO. Effects of increased plasma fatty acids on glycogen utilization and endurance. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 1977;43:829-833.
3. Fernandez C, Hansson O, Nevsten P, Holm C, Klint C. Hormone-sensitive lipase is necessary for normal mobilization of lipids during submaximal exercise. Am. J. Physiol. Endocrinol. Metab. 2008;295:E179-E186.
4. Huijsman E, van de Par C, Economou C, van der Poel C, Lynch GS, Schoiswohl G, Haemmerle G, Zechner R, Watt MJ. Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice. Am. J. Physiol. Endocrinol. Metab. 2009;297:E505-E513.
5. Schoiswohl G, Schweiger M, Schreiber R, Gorkiewicz G, Preiss-Landl K, Taschler U, Zierler KA, Radner FP, Eichmann TO, Kienesberger PC, Eder S, Lass A, Haemmerle G, Alsted TJ, Kiens B, Hoefler G, Zechner R, Zimmermann R. Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids. J. Lipid Res. 2010;51:490-499.
6. Tunstall RJ, Cameron-Smith D. Effect of elevated lipid concentrations on human skeletal muscle gene expression. Metabolism. 2005;54:952-959.
7. Civitarese AE, Hesselink MK, Russell AP, Ravussin E, Schrauwen P. Glucose ingestion during exercise blunts exercise-induced gene expression of skeletal muscle fat oxidative genes. Am. J. Physiol. Endocrinol. Metab. 2005;289:E1023-E1029.
8. Hoeks J, van Baak MA, Hesselink MK, Hul GB, Vidal H, Saris WH, Schrauwen P. Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. Am. J. Physiol. Endocrinol. Metab. 2003;285:E775-E782.
9. Schwenk RW, Holloway GP, Luiken JJ, Bonen A, Glatz JF. Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot. Essent. Fatty Acids. 2010;82:149-154.
10. McFarlan JT, Yoshida Y, Jain SS, Han XX, Snook LA, Lally J, Smith BK, Glatz JF, Luiken JJ, Sayer RA, Tupling AR, Chabowski A, Holloway GP, Bonen A. In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation. J. Biol. Chem. 2012;287:23502-23516.
11. Simonson DC, DeFronzo RA. Indirect calorimetry: methodological and interpretative problems. Am J Physiol. 1990;258:E399-E412.
12. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 2005;11:90-94.
13. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, Iida K, Choquet H, Besnard P, Lecoeur C, Vivequin S, Ayukawa K, Takeuchi M, Ozawa K, Tauber M, Maffeis C, Morandi A, Buzzetti R, Elliott P, Pouta A, Jarvelin MR, Körner A, Kiess W, Pigeyre M, Caiazzo R, Van Hul W, Van Gaal L, Horber F, Balkau B, Lévy- Marchal C, Rouskas K, Kouvatsi A, Hebebrand J, Hinney A, Scherag A, Pattou F, Meyre D, Koshimizu TA, Wolowczuk I, Tsujimoto G, Froguel P. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature. 2012;483:350-354.
14. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687-698.
15. Cornall LM, Mathai ML, Hryciw DH, McAinch AJ. Dietinduced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner. Cell. Physiol. Biochem. 2011;28:949-958.
16. 2+ signaling in taste bud cells and spontaneous preference for fat: unresolved roles of CD36 and GPR120. Biochimie. 2014;96:8-13.
17. Sundaresan S, Shahid R, Riehl TE, Chandra R, Nassir F, Stenson WF, Liddle RA, Abumrad NA. CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. FASEB J. 2013;27:1191-1202.
18. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch. Pharmacol. 2008;377:523-527.
19. Christiaens V, Van Hul M, Lijnen HR, Scroyen I. CD36 promotes adipocyte differentiation and adipogenesis. Biochim. Biophys. Acta. 2012;1820:949-956.
20. Gotoh C, Hong YH, Iga T, Hishikawa D, Suzuki Y, Song SH, Choi KC, Adachi T, Hirasawa A, Tsujimoto G, Sasaki S, Roh SG. The regulation of adipogenesis through GPR120. Biochem. Biophys. Res. Commun. 2007;354:591-597.
21. Cai L, Wang Z, Ji A, Meyer JM, van der Westhuyzen DR. Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity. PLoS One. 2012;7:e36785.
22. Ishihara K, Oyaizu S, Mizunoya W, Fukuchi Y, Yasumoto K, Fushiki T. Use of 13C-labeled glucose for measuring exogenous glucose oxidation in mice. Biosci. Biotechnol. Biochem. 2002;66: 426-429.
23. Matsumura S, Saitou K, Miyaki T, Yoneda T, Mizushige T, Eguchi A, Shibakusa T, Manabe Y, Tsuzuki S, Inoue K, Fushiki T. Mercaptoacetate inhibition of fatty acid beta-oxidation attenuates the oral acceptance of fat in BALB/c mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;295:R82-R91.
24. Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, Luster AD, Freeman MW. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 2002;277:47373-47379.
25. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest. 2002;109:1381-1389.
26. Goudriaan JR, den Boer MA, Rensen PC, Febbraio M, Kuipers F, Romijn JA, Havekes LM, Voshol PJ. CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance. J. Lipid Res. 2005;46:2175-2181.
27. Goudriaan JR, Dahlmans VE, Febbraio M, Teusink B, Romijn JA, Havekes LM, Voshol PJ. Intestinal lipid absorption is not affected in CD36 deficient mice. Mol. Cell. Biochem. 2002;239:199-202.
28. Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol. Rev. 2012;92:1061-1085.
29. Masuda D, Hirano K, Oku H, Sandoval JC, Kawase R, Yuasa-Kawase M, Yamashita Y, Takada M, Tsubakio-Yamamoto K, Tochino Y, Koseki M, Matsuura F, Nishida M, Kawamoto T, Ishigami M, Hori M, Shimomura I, Yamashita S. Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J. Lipid Res. 2009;50:999-1011.
30. Drover VA, Ajmal M, Nassir F, Davidson NO, Nauli AM, Sahoo D, Tso P, Abumrad NA. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest. 2005;115:1290-1297.
31. Nickerson JG, Alkhateeb H, Benton CR, Lally J, Nickerson J, Han XX, Wilson MH, Jain SS, Snook LA, Glatz JF, Chabowski A, Luiken JJ, Bonen A. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J. Biol. Chem. 2009;284:16522-16530.
32. Jain SS, Chabowski A, Snook LA, Schwenk RW, Glatz JF, Luiken JJ, Bonen A. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett. 2009;583:2294-2300.
33. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 1993;268:17665-17668.
34. Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, Romijn JA, Havekes LM, Voshol PJ. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J. Lipid Res. 2003;44:2270-2277.
35. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 1999;274:19055-19062.
36. Sandoval JC, Nakagawa-Toyama Y, Masuda D, Tochino Y, Nakaoka H, Kawase R, Yuasa-Kawase M, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Komuro I, Yamashita S. Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice. J. Atheroscler. Thromb. 2010;17:610-618.
37. Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am. J. Physiol. Endocrinol. Metab. 2007;292:E1740-E1749.